Home > PS Ratio > NEULAND LABORATORIES

NEULAND LABORATORIES
PS (Price/Sales) Ratio

The Current P/S Ratio of NEULAND LABORATORIES is 16.89.

Share Price ₹17,552.8Nov 06,2025
Market Cap ₹22,467.6 Cr
Sales-TTM₹1,330.0 CrTTM-Consolidated Results
Price/Sales16.89xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of NEULAND LABORATORIES

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of NEULAND LABORATORIES is calculated as :

Current Market Cap [ ₹22,467.6 Cr] as on Nov 06,2025

(/) Sales [ ₹1,330.0 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 16.89x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for NEULAND LABORATORIES , the investors are currently willing to pay '16.89 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of NEULAND LABORATORIES !

The chart below summarizes the trend in P/S Ratio of NEULAND LABORATORIES over the last five years.

Historical PS (Price/Sales) ratio chart of NEULAND LABORATORIES


PS Ratio Performance Analysis for NEULAND LABORATORIES

- NEULAND LABORATORIES 's latest p/e ratio is 16.89x.

- NEULAND LABORATORIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 4.37x.

- NEULAND LABORATORIES 's operated at median p/e ratio of 2.86x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, NEULAND LABORATORIES 's p/e ratio peaked in Mar2025 at 10.49x.

- NEULAND LABORATORIES 's p/e ratio hit its five-year low in Mar2022 of 1.38x.


How does NEULAND LABORATORIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
NEULAND LABORATORIES 1,330.016.8922,467.6
SUN PHARMACEUTICAL INDUSTRIES LTD54,964.07.36404,468.0
DIVIS LABORATORIES LTD9,652.018.94182,810.0
CIPLA LTD28,349.64.27121,170.0
TORRENT PHARMACEUTICALS LTD11,835.010.16120,300.0
DR REDDYS LABORATORIES LTD34,310.02.93100,575.0
MANKIND PHARMA LTD13,576.97.0295,320.4
ZYDUS LIFESCIENCES LTD24,493.93.8594,208.7
LUPIN LTD23,375.93.8289,345.0
AUROBINDO PHARMA LTD32,514.52.0466,243.3
ABBOTT INDIA LTD6,714.49.3362,639.1

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs NEULAND LABORATORIES 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.04x
Max industry PS 18.94x
Median industry PS 7.02x
Average industry PS 7.87x



You may also like the below Video Courses